Antibody validation for reproducible flow cytometry analysis

Live webinar

Producing consistent data in flow cytometry experiments is a challenging endeavor. Besides instrument-related issues, inconsistent reagents are a key source of irreproducible results.

In this webinar, Mona Al-Maarri highlights how Miltenyi Biotec’s antibody production and validation efforts improve the quality and reproducibility of your flow cytometry results. In this 30-minute presentation, you will learn about:

  • The antibody-related reproducibility crisis
  • Common causes of low reproducibility in flow cytometry experiments and lot-to-lot variations of antibody reagents
  • Recombinant antibodies and how they improve reproducibility
  • Quality control and validation steps employed in Miltenyi Biotec´s antibody production

There will be time for questions and discussion after the 30-minute webinar.

 

Sessions (choice of two dates)

November 5, 2019
Europe Time (Berlin, GMT+01:00) – 7:00 PM
Eastern Standard Time (New York, GMT-05:00) – 01:00 PM
Pacific Standard Time (San Francisco, GMT-08:00) – 10:00 AM

Register here

November 7, 2019
Europe Time (Berlin, GMT+01:00) – 10:00 AM 
London, United Kingdom (GMT time) –  9:00 AM 
Singapore, Singapore (GMT+08:00) – 5:00 PM  

Register here

 

About the presenter

Mona Al-Maarri completed her Ph.D. at the Max Planck Institute in Cologne, where she worked in the fields of Cancer Research, Metabolism, and Immunology, acquiring expert knowledge in Cell Separation and Flow Cytometry. She joined Miltenyi Biotec’s Marketing team in August 2018 as a global product manager, and is responsible for both the mass cytometry and flow cytometry antibody portfolios, including the co-ordination of dedicated marketing activities.

Mona Al Maarri,  Miltenyi Biotec